Pay in 4 interest-free payments of $5.45 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Digestive Symptoms Oral or injectable components may be associated with digestive discomfort, appetite changes, nausea or changes in bowel habits in some patients
Zepbound is simply the FDA-approved brand-name version of tirzepatide, manufactured by Eli Lilly
Clinical evidence suggests tirzepatide produces weight loss approximately 15 to 20 percent faster than semaglutide at comparable timepoints, likely due to its dual GIP/GLP-1 mechanism
[1] [4] For weight management, Zepbound is indicated for adults with a BMI 30 kg/m or 27 kg/m with at least one weight-related comorbidity
US$ 29.84
US$ 24.93
US$ 26.20
US$ 20.95
US$ 23.43
